001432966 000__ 08744cam\a2200577\a\4500
001432966 001__ 1432966
001432966 003__ OCoLC
001432966 005__ 20230309003542.0
001432966 006__ m\\\\\o\\d\\\\\\\\
001432966 007__ cr\un\nnnunnun
001432966 008__ 201217s2021\\\\sz\\\\\\o\\\\\001\0\eng\d
001432966 019__ $$a1227391974$$a1228842735$$a1236894788$$a1237461121$$a1238203559$$a1240719389$$a1251804461
001432966 020__ $$a9783030619190$$q(electronic bk.)
001432966 020__ $$a3030619192$$q(electronic bk.)
001432966 020__ $$z3030619184
001432966 020__ $$z9783030619183
001432966 0247_ $$a10.1007/978-3-030-61919-0$$2doi
001432966 035__ $$aSP(OCoLC)1227241439
001432966 040__ $$aYDX$$beng$$epn$$cYDX$$dGW5XE$$dOCLCO$$dUPM$$dOCLCF$$dEBLCP$$dDCT$$dUKAHL$$dN$T$$dOCLCO$$dOCL$$dDKU$$dOCLCO$$dOCLCQ$$dOCLCO$$dCOM$$dOCLCO$$dOCLCQ
001432966 049__ $$aISEA
001432966 050_4 $$aRC280.T6
001432966 08204 $$a616.99/444$$223
001432966 24500 $$aThyroid cancer :$$ba case-based approach /$$cGiorgio Grani, David S. Cooper, Cosimo Durante, editors.
001432966 250__ $$a2nd ed.
001432966 260__ $$aCham :$$bSpringer,$$c2021.
001432966 300__ $$a1 online resource
001432966 336__ $$atext$$btxt$$2rdacontent
001432966 337__ $$acomputer$$bc$$2rdamedia
001432966 338__ $$aonline resource$$bcr$$2rdacarrier
001432966 347__ $$atext file
001432966 347__ $$bPDF
001432966 500__ $$aIncludes index.
001432966 5050_ $$aPart I: Differentiated Thyroid Cancer: Initial Management -- 1.A Patient with a Single Thyroid Nodule Suspicious for Follicular Neoplasm According to the Bethesda System for Reporting Thyroid Cytopathology: Molecular Evaluation -- 2.A Young Patient with Intrathyroidal Papillary Thyroid Cancer and Family History of Differentiated Thyroid Cancer -- 3.A Case of a Small (1-2 cm) Papillary Thyroid Cancer in a Young Patient: Lobectomy Versus Total Thyroidectomy -- 4.A Patient with Papillary Microcarcinoma Undergoing Active Surveillance -- 5.Completion Thyroidectomy in a Patient with Low-Risk Papillary Cancer -- 6.A Papillary Thyroid Cancer with Minimal Extra-thyroidal Extension -- 7.A small Papillary Thyroid Cancer with angioinvasion -- 8.A patient with a pathological diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) -- 9. Papillary Thyroid Cancer with Central Neck Lymph Node Metastases -- 10.A Patient with a Large Minimally Invasive Follicular Thyroid Cancer -- 11.A Child with Papillary Thyroid Cancer and Locally Advanced Disease but No Distant Metastasis -- Part II: Differentiated Thyroid Cancer: Postoperative Follow-Up -- 12.A Patient with Papillary Thyroid Cancer and Biochemical Evidence of Disease at the One-Year Follow-Up Visit -- 13.A Patient with Low Risk Papillary Thyroid Cancer Who Has Undergone a Lobectomy: Monitoring for Recurrent Disease and Assessment of Thyroid Function.-14.A Patient with Papillary Thyroid Carcinoma and Biochemical Evidence of Disease at Follow-Up Visits with Increasing Serum Tg Values at the Follow-Up Assessments -- 15.A Young Patient with Recurrent Lymph Node Involvement: Imaging, Cytology, and Thyroglobulin Washout -- Part III: Differentiated Thyroid Cancer: Special Issues -- 16. Papillary Thyroid Carcinoma Diagnosed During Pregnancy -- 17. Risks of Thyroid Hormone Suppression for Differentiated Thyroid Cancer in the Elderly -- 18.A Case with Postsurgical Hypoparathyroidism -- 19.A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring -- Part IV: Differentiated Thyroid Cancer: Managing higher risk patients -- 20.A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient -- 21.A Patient with a Large Hürthle Cell Carcinoma of the Thyroid and Nodal Metastases -- 22.A Case of a Large, Invasive PTC with Gross Residual Disease (pT4) After Surgery -- 23.A Patient with Papillary Carcinoma of the Thyroid with Elevated Serum Thyroglobulin but Negative Imaging Studies -- 24.A Young Child with Papillary Thyroid Cancer and Metastatic Pulmonary Disease: Role of Radioactive Iodine Therapy in Children -- 25.A Patient with Bone Metastases from Follicular Carcinoma of the Thyroid -- 26. Radioiodine Therapy in Lactating Women with Higher-Risk Differentiated Thyroid Cancer -- Part V: Differentiated Thyroid Cancer: Beyond Radioactive Iodine Therapy -- 27.A Case of a Patient with Radioactive Iodine Refractory Differentiated Thyroid Cancer with Progressive Neck Disease (Latero-cervical Lymph Nodes) and Stable, Small Lung Metastases -- 28. A Case of a Patient with High Risk Papillary Thyroid Cancer With Gross Residual Disease after Initial Thyroidectomy: Role of External Beam Radiotherapy -- 29. RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease -- 30. RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding -- 31.A Patient with Follicular Thyroid Cancer and a Painful Bone Metastases at Risk for Pathologic Fracture -- 32. Differentiated Thyroid Cancer and Brain Metastases -- 33. RAI-Refractory, Advanced Differentiated Thyroid Cancer Receiving Tyrosine Kinase Inhibitor Treatment: Checking for Drug-Drug Interactions -- Part VI: Medullary Thyroid Cancer -- 34. Management of Postoperative Hypercalcitoninemia in MTC -- 35.A Patient with Metastatic Medullary Thyroid Carcinoma (MTC) and Tumor-Related Diarrhea -- 36. Clinical Management of a Patient with a Locally Recurrent Medullary Thyroid Cancer and Asymptomatic Slowly Progressing Distant Metastases -- 37.A Patient with an Advanced Medullary Thyroid Cancer and Progressive, Symptomatic Distant Metastases: When to Start Systemic Therapy -- 38. Medical Treatment Decision-Making for Advanced, Progressive Medullary Thyroid Cancer -- 39. Screening Leading to Diagnosis of C-Cell Hyperplasia -- 40. Increased Basal Calcitonin in Nodular Goiter: Is It Micromedullary Thyroid Cancer? -- 41. Timing and Extent of Surgery for a Pediatric Patient with Hereditary MTC and Positive Screening for the S891A RET Mutation -- Part VII: Anaplastic Thyroid Cancer -- 42. Anaplastic Thyroid Cancer: Surgery or Not in Locally Advanced Disease -- 43.A Patient with BRAFV600E-mutated Anaplastic Thyroid Cancer with Metastatic Disease.
001432966 506__ $$aAccess limited to authorized users.
001432966 520__ $$aNow in its second edition utilizing brand new clinical case material, this popular, user-friendly text presents the diagnosis and treatment of thyroid cancer and related clinical issues, providing clinicians in endocrinology and oncology with the best real-world strategies to properly manage the various manifestations of thyroid cancer that they may encounter. Each chapter is a case report that opens with a unique clinical presentation, followed by a description of the diagnosis, assessment and therapy, as well as the case outcome, literature review, clinical pearls and pitfalls, and bibliography. All recommendations are based on evidence-based clinical practice guidelines and recent literature. Written by experts in the field, these cases illustrate treatment for both low- and high-risk differentiated thyroid cancer, including surgical approaches, radioiodine therapy, and novel chemotherapies and targeted therapies, as well as postoperative follow-up and special issues. Additional cases demonstrate the management of medullary thyroid cancer and anaplastic thyroid cancer. Topics new to the second edition include information on management of small thyroid cancers with "active surveillance" (without surgery), new chemotherapeutic approaches to advanced thyroid cancer, and new information on a lesion that is no longer considered to be thyroid cancer (Neoplastic Follicular Thyroid Neoplasm with Papillary-Like Features [NIFTP]), as well as material on external beam radiotherapy and new approaches to the management of anaplastic thyroid cancer. Pragmatic and reader-friendly, this second edition of Thyroid Cancer: A Case-Based Approach will be an excellent resource for clinical endocrinologists and oncologists, endocrine fellows, residents and students alike
001432966 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed February 25, 2021).
001432966 650_0 $$aThyroid gland$$xCancer$$vCase studies.
001432966 655_7 $$aCase studies.$$2fast$$0(OCoLC)fst01423765
001432966 655_7 $$aCase studies.$$2lcgft
001432966 655_7 $$aÉtudes de cas.$$2rvmgf
001432966 655_0 $$aElectronic books.
001432966 7001_ $$aGrani, Giorgio,$$eeditor.
001432966 7001_ $$aCooper, David S.$$c(Physician),$$eeditor.
001432966 7001_ $$aDurante, Cosimo,$$eeditor.
001432966 77608 $$iPrint version:$$tThyroid cancer.$$b2nd ed.$$dCham : Springer, 2021$$z3030619184$$z9783030619183$$w(OCoLC)1196244347
001432966 852__ $$bebk
001432966 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-61919-0$$zOnline Access$$91397441.1
001432966 909CO $$ooai:library.usi.edu:1432966$$pGLOBAL_SET
001432966 980__ $$aBIB
001432966 980__ $$aEBOOK
001432966 982__ $$aEbook
001432966 983__ $$aOnline
001432966 994__ $$a92$$bISE